Access brought to you by: LOCKSS

Oncology Clinical Trials

Docetaxel at Beginning of Androgen Deprivation Therapy Boosts Overall Survival by over 1 Year
Ramucirumab Improves Survival in Stage IV NSCLC
Lapatinib Plus Trastuzumab Was Not Superior to Trastuzumab Alone or Trastuzumab Followed by Lapatinib for Improved DFS in Women with HER2+ Breast Cancer
Obesity Linked to ER+ Breast Cancer Mortality in Premenopausal Women
Similar Benefit of Immediate or Deferred ADT in PSA-Only Relapsed Prostate Cancer
CALGB/SWOG 80405 Results Provide Treatment Options for mCRC
Goserelin Improves Ovarian Function in Premenopausal Women with Estrogen Receptor-Negative/Progesterone Receptor-Negative Breast Cancer
CRT with Oxaliplatin Improves DFS in Locally Advanced Rectal Cancer
Safety and Efficacy of Enzalutamide in Men with Metastatic Prostate Cancer: The PREVAIL Trial
Lenvatinib Improves Progression-Free Survival in Refractory Thyroid Cancer

Pages